Name Patient Program, often referred to as NPP, are initiatives established to provide controlled and regulated access to investigational or unapproved medical treatments for patients who have exhausted other treatment options and meet specific eligibility criteria.

The primary purpose of Name patient program is to offer access to potentially life-saving or disease-altering therapies when the prescribed Medicines not approved in the patient’s country but are approved and available in at other countries.

These programs go by various names, including Compassionate Use, Manage Access Program, and Individual Patient Request, among others. The terminology may vary depending on the region and its regulatory framework.

Alleviare Life Sciences assists eligible patients to access specific medicines. To initiate a request, the treating physician or the patient in need of a particular medicinal product must submit the request to Alleviare.